Relationship between PPAR-γ gene polymorphisms and ischemic stroke risk: A meta-analysis
Fan Cheng1, Xiao-Min Si1,2, Gong-Li Yang3
1Center of Cardiopulmonary Rehabilitation, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
This meta-analysis found that the PPAR-γ rs1801282 C/G gene polymorphism is associated with an increased risk of ischemic stroke (IS). Further research is needed to confirm these findings on PPAR-γ and IS development.
Area of Science:
- Genetics
- Neurology
- Molecular Biology
Background:
- Emerging research suggests a link between Peroxisome proliferator-activated receptor gamma (PPAR-γ) and the development of ischemic stroke (IS).
- Genetic variations in PPAR-γ may influence an individual's susceptibility to IS.
Purpose of the Study:
- To conduct a meta-analysis evaluating the association between specific PPAR-γ gene polymorphisms (rs1801282 C/G and rs3856806 C/T) and the risk of developing IS.
- To synthesize existing evidence to provide a clearer understanding of the genetic contribution to IS.
Main Methods:
- A systematic literature search was performed across major scientific databases (PubMed, Embase, Web of Science, CNKI, WanFang).
- Meta-analysis techniques were employed to pool odds ratios (ORs) and 95% confidence intervals (CIs) for the selected PPAR-γ polymorphisms.
- Statistical analyses included heterogeneity testing, cumulative and sensitivity analyses, and publication bias assessment.
Main Results:
- Sixteen studies comprising 3786 cases and 5343 controls were included.
- The PPAR-γ rs1801282 C/G polymorphism was significantly associated with an increased risk of IS (GG vs. CC: OR=2.17, 95%CI=1.09-4.35; GG vs. CC+CG: OR=2.15, 95%CI=1.07-4.32).
- No significant association was found between the PPAR-γ rs3856806 C/T polymorphism and IS risk.
Conclusions:
- The PPAR-γ rs1801282 C/G polymorphism likely plays a role in the occurrence of ischemic stroke.
- These findings highlight a potential genetic marker for IS risk, but require validation through additional prospective studies.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...


